Arrowstreet Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107M | Buy |
2,976,480
+1,615,706
| +119% | +$58.2M | 0.08% | 246 |
|
|
2025
Q1 | $42.4M | Buy |
1,360,774
+690,893
| +103% | +$21.5M | 0.03% | 404 |
|
|
2024
Q4 | $17.1M | Sell |
669,881
-720,342
| -52% | -$18.4M | 0.01% | 658 |
|
|
2024
Q3 | $39.3M | Buy |
1,390,223
+450,189
| +48% | +$12.7M | 0.03% | 382 |
|
|
2024
Q2 | $24.8M | Buy |
940,034
+57,288
| +6% | +$1.51M | 0.02% | 431 |
|
|
2024
Q1 | $26.8M | Sell |
882,746
-896,490
| -50% | -$27.2M | 0.02% | 441 |
|
|
2023
Q4 | $50M | Sell |
1,779,236
-174,006
| -9% | -$4.89M | 0.05% | 268 |
|
|
2023
Q3 | $53M | Buy |
1,953,242
+39,026
| +2% | +$1.06M | 0.06% | 240 |
|
|
2023
Q2 | $58.8M | Sell |
1,914,216
-41,909
| -2% | -$1.29M | 0.07% | 220 |
|
|
2023
Q1 | $70.5M | Sell |
1,956,125
-542,745
| -22% | -$19.6M | 0.09% | 210 |
|
|
2022
Q4 | $98.8M | Buy |
2,498,870
+577,444
| +30% | +$22.8M | 0.14% | 161 |
|
|
2022
Q3 | $77.2M | Buy |
1,921,426
+864,871
| +82% | +$34.8M | 0.11% | 174 |
|
|
2022
Q2 | $44.4M | Buy |
1,056,555
+464,078
| +78% | +$19.5M | 0.06% | 236 |
|
|
2022
Q1 | $23.1M | Buy |
+592,477
| New | +$23.1M | 0.03% | 376 |
|
|
2021
Q4 | – | Sell |
-59,330
| Closed | -$2.14M | – | 1682 |
|
|
2021
Q3 | $2.14M | Buy |
+59,330
| New | +$2.14M | ﹤0.01% | 1117 |
|
|
2021
Q2 | – | Sell |
-17,900
| Closed | -$781K | – | 2169 |
|
|
2021
Q1 | $781K | Buy |
+17,900
| New | +$781K | ﹤0.01% | 1872 |
|
|
2020
Q4 | – | Sell |
-294,481
| Closed | -$12.4M | – | 2502 |
|
|
2020
Q3 | $12.4M | Buy |
+294,481
| New | +$12.4M | 0.02% | 745 |
|